Back
Akero Therapeutics Stock Predictions
AI Is Disrupting Marketing - Invest in the Shift
Invest Now & Be Part of RAD Intel's Breakout Year
Sell
21
AKRO
Akero Therapeutics
Last Price:
$45.90
Seasonality Move:
-20.18%
7 Day Trial
ALL ACCESS PASS
$
7
Your Data Made Them Billions-Now It's Your Turn to Profit
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Akero Therapeutics Stock Forecast
-
Over the next 52 weeks, Akero Therapeutics has on average historically risen by 40.3% based on the past 5 years of stock performance.
-
Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Akero Therapeutics Stock Undervalued?The current Akero Therapeutics [AKRO] share price is $43.85. The Score for AKRO is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Akero Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Akero Therapeutics has on average historically risen by 40.3% based on the past 5 years of stock performance.
Akero Therapeutics Stock Rating
Sell
21
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics overpriced?
-
Akero Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Akero Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
akerotx.com
52-Week Data
52-Week High:
58.40
52-Week Low:
17.86
Prediction Charts
Market Cap:
3.5B
Price in USD:
43.85
Volume:
1.3M
Beta:
-0.13
Technical Analysis
SMA50:
40.07
SMA100:
35.44
SMA200:
30.17
52-Wk Change:
49.59%
Stock Predictions
-
Is Akero Therapeutics stock public?Yes, Akero Therapeutics is a publicly traded company.
-
What is the Akero Therapeutics stock quote today?The Akero Therapeutics stock price is 43.85 USD today.
-
How to buy Akero Therapeutics stock online?You can buy Akero Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-18 | 51.39 | 49.44 | 51.39 | 49.35 |
| Feb-19 | 49.46 | 50.67 | 50.76 | 48.70 |
| Feb-20 | 50.82 | 50.58 | 51.39 | 50.12 |
| Feb-21 | 51.46 | 51.79 | 52.74 | 51.09 |
| Feb-25 | 49.66 | 47.47 | 49.66 | 46.87 |
| Feb-26 | 47.69 | 47.59 | 48.97 | 46.55 |
| Feb-27 | 47.00 | 47.78 | 49.51 | 46.66 |
| Feb-28 | 48.66 | 49.25 | 49.25 | 46.31 |
| Mar-3 | 48.09 | 45.54 | 48.78 | 45.47 |
| Mar-4 | 44.97 | 44.56 | 45.65 | 43.63 |
| Mar-5 | 44.82 | 45.16 | 45.64 | 43.70 |
| Mar-6 | 44.56 | 43.64 | 44.94 | 43.51 |
| Mar-7 | 43.50 | 42.10 | 43.94 | 42.04 |
| Mar-11 | 41.70 | 43.85 | 43.92 | 41.61 |
Akero Therapeutics Earnings
Akero Therapeutics Earnings Report: Per Share Akero Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Akero Therapeutics Forecast Revenue Growth
Akero Therapeutics Stock Analysis: Historical quarterly revenues per share for Akero Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.63 per share.
* Akero Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.